Annual Report 2018

[Pages:45]Annual Report 2018

19 February 2019

S?ren Nielsen, President & CEO Ren? Schneider, CFO

Agenda

01 Name change and strategic rationale 02 2018 highlights 03 Update on business activities 04 Financial update 05 2019, a year of strong product introductions 06 Outlook 2019 07 Q&A

2

William Demant Holding

changes name to

3

Attractive growth in hearing healthcare

Structural growth drivers ? Baby-boomers in developed markets ? Ageing population across the world

Hearing care is healthcare

? Hearing loss may accelerate cognitive decline and lead to social isolation

? Biggest modifiable risk factor related to dementia

Hearing Devices 2-4%

Diagnostic 2017

Instruments

Diagnostic 2027

Instruments

Hearing Implants 10-15%

Diagnostic Instruments 3-5%

Hearing Implants

Hearing Devices

CAGR ~5%

Hearing Implants

Hearing Devices

Note: Wholesale values

4

Strategic ambition

Life-changing hearing health

6

2018 highlights

7

2018 highlights

9% Strong revenue growth of 9% in local currencies with substantial organic sales growth of 7%

9% organic growth in wholesale business and market share gains in value despite slowdown towards end of year ? product portfolio to be expanded with new premium products based on new platform

9% growth in local currencies in hearing aid retail business driven by acquisitive growth of 8% and organic growth of 1% with material differences between markets

Underlying organic growth of 10% in Hearing Implants driven by roll-out of Neuro 2 (adjusted for decision to reduce activity level in select cochlear implants markets with lower prices). Reported organic growth was 5%

Exceptional organic growth of 12% in Diagnostic Instruments and continued market share gains

Unprecedented level of resources used for R&D and digitalisation to drive future growth

8%

8% growth in reported EBIT to DKK 2,532 million. 6% growth in adjusted EBIT to DKK 2,652 million (vs. guidance range of DKK 2.65-2.85 billion, originally DKK 2.55-2.85 billion)

Outlook 2019: Reported EBIT of DKK 2.65-2.95 billion and share buy-backs worth a minimum of DKK 1.2 billion

8

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download